Verrica Pharmaceuticals Inc (VRCA)
8.69
-0.46
(-5.03%)
USD |
NASDAQ |
May 20, 16:00
8.69
0.00 (0.00%)
After-Hours: 20:00
Verrica Pharmaceuticals Shareholders Equity (Quarterly): 1.508M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 1.508M |
December 31, 2023 | 19.76M |
September 30, 2023 | 42.30M |
June 30, 2023 | 55.40M |
March 31, 2023 | 64.85M |
December 31, 2022 | 40.03M |
September 30, 2022 | 44.76M |
June 30, 2022 | 16.33M |
March 31, 2022 | 25.42M |
December 31, 2021 | 32.60M |
September 30, 2021 | 40.85M |
June 30, 2021 | 52.16M |
March 31, 2021 | 61.81M |
Date | Value |
---|---|
December 31, 2020 | 32.99M |
September 30, 2020 | 39.18M |
June 30, 2020 | 48.46M |
March 31, 2020 | 56.61M |
December 31, 2019 | 65.02M |
September 30, 2019 | 71.65M |
June 30, 2019 | 76.84M |
March 31, 2019 | 82.76M |
December 31, 2018 | 89.43M |
September 30, 2018 | 96.35M |
June 30, 2018 | 101.59M |
March 31, 2018 | 27.75M |
December 31, 2017 | -7.041M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
1.508M
Minimum
Mar 2024
76.84M
Maximum
Jun 2019
44.43M
Average
43.53M
Median
Shareholders Equity (Quarterly) Benchmarks
Emergent BioSolutions Inc | 663.90M |
Macrogenics Inc | 106.15M |
Aquestive Therapeutics Inc | -36.30M |
Recursion Pharmaceuticals Inc | 401.15M |
Omega Therapeutics Inc | 41.35M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 66.31M |
Total Liabilities (Quarterly) | 64.80M |
Debt to Equity Ratio | 28.41 |
Current Ratio | 3.169 |
Net Debt Paydown Yield | -3.41% |